Molecular genetics, diagnosis and management of clear cell sarcoma of hand

Abstract

Synonyms: Clear cell sarcoma of soft tissue, Clear cell sarcoma of the tendons and aponeuroses, malignant melanoma of the soft parts. Background: Rodriguez-Martin, Ortiz-Cruz, Del Rio, Vivanco, & Lopaz-Amor in 2011 stated “Clear cell sarcoma is a high-grade soft tissue sarcoma seen in adolescents and young adults, with melanosytic differentiation typically involving tendons and aponeuroses”. Clear cell sarcoma of soft tissue (CCSST) was originally described by Dr. Franz M. Enzinger in 1965 as a distinct entity of tumors arising from tendons and aponeuroses in young adults. Clear cell sarcoma (CCS) of soft tissue is a rare sarcoma with morphologic similarities to malignant melanoma. They are characterized by a distinct genetic background including a chromosomal translocation t(12;22)(q13;q12), or a resultant EWSR1-ATF1 fusion gene. The lower limbs are involved more commonly. Clear cell sarcoma has been reported in other tissues such as bone, colon and gastrointestinal tract. The clear cell sarcoma that occurs in relation to the gastrointestinal tract has a variant fusion gene EWSR1-CREB1 and they are re-designated as gastrointestinal neuroectodermal tumor (GNET). Material and method: A 21 years old female with a chronic recurrent swelling of the left mid finger was diagnosed as epithelioid sarcoma on histopathological examination. Immunohistochemistry was done with basic tumor markers panel and a diagnosis of clear cell sarcoma was confirmed. Result: Immunohistochemistry staining is used for sub-typing of the tumor, predicts the prognosis of the tumor and also the response to the specific type of therapy.